{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T06:57:53Z","timestamp":1760425073490},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2011,6,8]],"date-time":"2011-06-08T00:00:00Z","timestamp":1307491200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1007\/s00115-011-3321-8","type":"journal-article","created":{"date-parts":[[2011,6,6]],"date-time":"2011-06-06T14:58:18Z","timestamp":1307372298000},"page":"1273-1280","source":"Crossref","is-referenced-by-count":4,"title":["Ionenkanalmodulatoren bei Multipler Sklerose"],"prefix":"10.1007","volume":"82","author":[{"given":"S.","family":"Bittner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"H\u00f6hn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"G\u00f6bel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Kleinschnitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Wiendl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.G.","family":"Meuth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,6,8]]},"reference":[{"key":"3321_CR1","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.2174\/1381612054021006","volume":"11","author":"Armijo","year":"2005","unstructured":"Armijo JA, Shushtarian M, Valdizan EM et al (2005) Ion channels and epilepsy. Curr Pharm Des 11:1975\u20132003","journal-title":"Curr Pharm Des"},{"key":"3321_CR2","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/ana.20045","volume":"55","author":"Bechtold","year":"2004","unstructured":"Bechtold DA, Kapoor R, Smith KJ (2004) Axonal protection using flecainide in experimental autoimmune encephalomyelitis. Ann Neurol 55:607\u2013616","journal-title":"Ann Neurol"},{"key":"3321_CR3","doi-asserted-by":"crossref","unstructured":"Bechtold DA, Miller SJ, Dawson AC et al (2006) Axonal protection achieved in a model of multiple sclerosis using lamotrigine J Neurol 253:1542\u20131551","DOI":"10.1007\/s00415-006-0204-1"},{"key":"3321_CR4","doi-asserted-by":"crossref","first-page":"13942","DOI":"10.1073\/pnas.241497298","volume":"98","author":"Beeton","year":"2001","unstructured":"Beeton C, Wulff H, Barbaria J et al (2001) Selective blockade of T lymphocyte K(+) channels ameliorates experimental autoimmune encephalomyelitis a model for multiple sclerosis. Proc Natl Acad Sci U S A 98:13942\u201313947","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3321_CR5","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/ana.21007","volume":"60","author":"Beraud","year":"2006","unstructured":"Beraud E, Viola A, Regaya I et al (2006) Block of neural Kv1.1 potassium channels for neuroinflammatory disease therapy. Ann Neurol 60:586\u2013596","journal-title":"Ann Neurol"},{"key":"3321_CR6","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/ana.22010","volume":"68","author":"Bittner","year":"2010","unstructured":"Bittner S, Bobak N, Herrmann AM et al (2010) Upregulation of K2P5.1 potassium channels in multiple sclerosis. Ann Neurol 68:58\u201369","journal-title":"Ann Neurol"},{"key":"3321_CR7","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/j.1750-3639.2010.00407.x","volume":"20","author":"Bittner","year":"2010","unstructured":"Bittner S, Budde T, Wiendl H et al (2010) From the background to the spotlight: TASK channels in pathological conditions. Brain Pathol 20:999\u20131009","journal-title":"Brain Pathol"},{"key":"3321_CR8","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1093\/brain\/awp163","volume":"132","author":"Bittner","year":"2009","unstructured":"Bittner S, Meuth SG, Gobel K et al (2009) TASK1 modulates inflammation and neurodegeneration in autoimmune inflammation of the central nervous system. Brain 132:2501\u20132516","journal-title":"Brain"},{"key":"3321_CR9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/ana.21172","volume":"62","author":"Black","year":"2007","unstructured":"Black JA, Liu S, Carrithers M et al (2007) Exacerbation of experimental autoimmune encephalomyelitis after withdrawal of phenytoin and carbamazepine. Ann Neurol 62:21\u201333","journal-title":"Ann Neurol"},{"key":"3321_CR10","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1093\/brain\/awl057","volume":"129","author":"Black","year":"2006","unstructured":"Black JA, Waxman SG, Smith KJ (2006) Remyelination of dorsal column axons by endogenous Schwann cells restores the normal pattern of Nav1.6 and Kv1.2 at nodes of Ranvier. Brain 129:1319\u20131329","journal-title":"Brain"},{"key":"3321_CR11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1600-065X.2009.00816.x","volume":"231","author":"Cahalan","year":"2009","unstructured":"Cahalan MD, Chandy KG (2009) The functional network of ion channels in T lymphocytes. Immunol Rev 231:59\u201387","journal-title":"Immunol Rev"},{"key":"3321_CR12","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0920-1211(92)90065-2","volume":"13","author":"Cheung","year":"1992","unstructured":"Cheung H, Kamp D, Harris E (1992) An in vitro investigation of the action of lamotrigine on neuronal voltage-activated sodium channels. Epilepsy Res 13:107\u2013112","journal-title":"Epilepsy Res"},{"key":"3321_CR13","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1038\/nm1668","volume":"13","author":"Friese","year":"2007","unstructured":"Friese MA, Craner MJ, Etzensperger R et al (2007) Acid-sensing ion channel-1 contributes to axonal degeneration in autoimmune inflammation of the central nervous system. Nat Med 13:1483\u20131489","journal-title":"Nat Med"},{"key":"3321_CR14","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S1474-4422(10)70131-9","volume":"9","author":"Kapoor","year":"2010","unstructured":"Kapoor R, Furby J, Hayton T et al (2010) Lamotrigine for neuroprotection in secondary progressive multiple sclerosis a randomised, double-blind, placebo-controlled, parallel-group trial. Lancet Neurol 9:681\u2013688","journal-title":"Lancet Neurol"},{"key":"3321_CR15","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0002-9440(10)64537-3","volume":"157","author":"Kornek","year":"2000","unstructured":"Kornek B, Storch MK, Weissert R et al (2000) Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. Am J Pathol 157:267\u2013276","journal-title":"Am J Pathol"},{"key":"3321_CR16","doi-asserted-by":"crossref","first-page":"3566","DOI":"10.1152\/jn.00434.2003","volume":"90","author":"Lo","year":"2003","unstructured":"Lo AC, Saab CY, Black JA et al (2003) Phenytoin protects spinal cord axons and preserves axonal conduction and neurological function in a model of neuroinflammation in vivo. J Neurophysiol 90:3566\u20133571","journal-title":"J Neurophysiol"},{"key":"3321_CR17","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s00115-008-2599-7","volume":"80","author":"Meuth","year":"2009","unstructured":"Meuth SG, Melzer N, Kleinschnitz C et al (2009) Multiple sclerosis \u2013 a channelopathy? Targeting ion channels and transporters in inflammatory neurodegeneration. Nervenarzt 80:422\u2013429","journal-title":"Nervenarzt"},{"key":"3321_CR18","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0165-0173(01)00134-5","volume":"38","author":"Nashmi","year":"2001","unstructured":"Nashmi R, Fehlings MG (2001) Mechanisms of axonal dysfunction after spinal cord injury: with an emphasis on the role of voltage-gated potassium channels. Brain Res Brain Res Rev 38:165\u2013191","journal-title":"Brain Res Brain Res Rev"},{"key":"3321_CR19","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/ana.20703","volume":"58","author":"Polman","year":"2005","unstructured":"Polman CH, Reingold SC, Edan G et al (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the \u201eMcDonald Criteria\u201c. Ann Neurol 58:840\u2013846","journal-title":"Ann Neurol"},{"key":"3321_CR20","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1007\/s00018-007-7079-x","volume":"64","author":"Rosenberg","year":"2007","unstructured":"Rosenberg G (2007) The mechanisms of action of valproate in neuropsychiatric disorders: can we see the forest for the trees? Cell Mol Life Sci 64:2090\u20132103","journal-title":"Cell Mol Life Sci"},{"key":"3321_CR21","doi-asserted-by":"crossref","first-page":"11094","DOI":"10.1073\/pnas.0501770102","volume":"102","author":"Rus","year":"2005","unstructured":"Rus H, Pardo CA, Hu L et al (2005) The voltage-gated potassium channel Kv1.3 is highly expressed on inflammatory infiltrates in multiple sclerosis brain. Proc Natl Acad Sci U S A 102:11094\u201311099","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3321_CR22","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s00228-008-0523-5","volume":"64","author":"Tzellos","year":"2008","unstructured":"Tzellos TG, Papazisis G, Amaniti E et al (2008) Efficacy of pregabalin and gabapentin for neuropathic pain in spinal-cord injury: an evidence-based evaluation of the literature. Eur J Clin Pharmacol 64:851\u2013858","journal-title":"Eur J Clin Pharmacol"},{"key":"3321_CR23","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/brain\/awq337","volume":"134","author":"Vergo","year":"2011","unstructured":"Vergo S, Craner MJ, Etzensperger R et al (2011) Acid-sensing ion channel 1 is involved in both axonal injury and demyelination in multiple sclerosis and its animal model. Brain 134:571\u2013584","journal-title":"Brain"},{"key":"3321_CR24","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/ncpneuro0735","volume":"4","author":"Waxman","year":"2008","unstructured":"Waxman SG (2008) Mechanisms of disease: sodium channels and neuroprotection in multiple sclerosis-current status. Nat Clin Pract Neurol 4:159\u2013169","journal-title":"Nat Clin Pract Neurol"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-011-3321-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00115-011-3321-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-011-3321-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T12:55:04Z","timestamp":1560257704000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00115-011-3321-8"}},"subtitle":["Bestandsaufnahme der Anwendung in der Praxis"],"short-title":[],"issued":{"date-parts":[[2011,6,8]]},"references-count":24,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["3321"],"URL":"https:\/\/doi.org\/10.1007\/s00115-011-3321-8","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,8]]}}}